Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation.
Journal Information
Full Title: Ther Adv Psychopharmacol
Abbreviation: Ther Adv Psychopharmacol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pharmacology & Pharmacy
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: OC has received honorariums from AbbVie, Janssen Canada and Otsuka-Lundbeck Alliance. MFD has received grants from AbbVie, Janssen Canada and Otsuka-Lundbeck Alliance. MAR has received grants from AbbVie, Janssen Canada, Mylan, Otsuka-Lundbeck Alliance, and Sunovion. All other authors have no conflicts of interest that are directly relevant to the content of this study."
"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by Janssen Canada."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025